CO6321156A2 - Composicion farmaceutica para el uso en el tratamiento de infecciones de transmision sexual - Google Patents

Composicion farmaceutica para el uso en el tratamiento de infecciones de transmision sexual

Info

Publication number
CO6321156A2
CO6321156A2 CO11036830A CO11036830A CO6321156A2 CO 6321156 A2 CO6321156 A2 CO 6321156A2 CO 11036830 A CO11036830 A CO 11036830A CO 11036830 A CO11036830 A CO 11036830A CO 6321156 A2 CO6321156 A2 CO 6321156A2
Authority
CO
Colombia
Prior art keywords
treatment
pharmaceutical composition
sexual transmission
infections
pharmaceutically acceptable
Prior art date
Application number
CO11036830A
Other languages
English (en)
Inventor
Lopez Raul Salgado
Paniagua Angelica Arzola
Pelaez Juan Pablo Senosiain
Hernandez Gustavo Barranco
Original Assignee
Senosiain S A De C V Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41796784&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6321156(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Senosiain S A De C V Lab filed Critical Senosiain S A De C V Lab
Publication of CO6321156A2 publication Critical patent/CO6321156A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica oral sólida que comprende la combinación fluconazol, tinidazol y clindamicina y/o una sal farmacéuticamente aceptable de los mismos; donde el contenido de excipientes farmacéuticamente aceptables es significativamente menor que el contenido que los principios activos, el uso de dicha composición para la administración oral con actividad terapéutica para el tratamiento de infecciones de transmisión sexual.
CO11036830A 2008-09-04 2011-03-25 Composicion farmaceutica para el uso en el tratamiento de infecciones de transmision sexual CO6321156A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2008011321A MX2008011321A (es) 2008-09-04 2008-09-04 Composicion farmaceutica para el uso en el tratamiento de infecciones de transmision sexual.

Publications (1)

Publication Number Publication Date
CO6321156A2 true CO6321156A2 (es) 2011-09-20

Family

ID=41796784

Family Applications (1)

Application Number Title Priority Date Filing Date
CO11036830A CO6321156A2 (es) 2008-09-04 2011-03-25 Composicion farmaceutica para el uso en el tratamiento de infecciones de transmision sexual

Country Status (13)

Country Link
US (1) US20110166087A1 (es)
EP (1) EP2329819B1 (es)
KR (1) KR101653424B1 (es)
BR (1) BRPI0918593B8 (es)
CA (1) CA2735926C (es)
CO (1) CO6321156A2 (es)
EC (1) ECSP11010941A (es)
ES (1) ES2734280T3 (es)
HN (1) HN2011000661A (es)
MX (1) MX2008011321A (es)
PE (1) PE20110448A1 (es)
UY (1) UY32091A (es)
WO (1) WO2010026469A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113768883A (zh) * 2021-08-25 2021-12-10 海南海神同洲制药有限公司 一种高稳定性盐酸克林霉素棕榈酸酯颗粒的制备方法
CN113768885A (zh) * 2021-09-16 2021-12-10 海南海神同洲制药有限公司 一种伏立康唑干混悬剂的制备工艺
CN114306209A (zh) * 2022-01-10 2022-04-12 江苏远恒药业有限公司 一种替硝唑栓的组合物及其制备方法与应用
CN116251067B (zh) * 2023-04-23 2024-06-07 淄博市中心医院 一种氟康唑片、制备方法及用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7094431B2 (en) 2000-10-12 2006-08-22 Mickey L. Peshoff Method of healing skin wounds in mammals and a composition therefor
MXPA02007641A (es) * 2002-08-08 2004-04-02 Alparis Sa De Cv Uso de farmaceutico de la combinacion de fluconazol-tinidazol y su composicion para la administracion oral.
US8309103B2 (en) 2004-01-22 2012-11-13 Alparis, S.A. De C.V. Association of fluconazole-tinidazole for the treatment of vaginal infections, its composition, preparation process and usage
US20070154516A1 (en) * 2006-01-05 2007-07-05 Drugtech Corporation Drug delivery system
US20080003262A1 (en) * 2006-06-30 2008-01-03 Drugtech Corporation Compositions and therapeutic methods of use

Also Published As

Publication number Publication date
PE20110448A1 (es) 2011-07-20
ES2734280T3 (es) 2019-12-05
BRPI0918593A8 (pt) 2018-12-11
CA2735926C (en) 2016-09-06
ECSP11010941A (es) 2011-06-30
EP2329819B1 (en) 2019-05-01
UY32091A (es) 2010-02-26
BRPI0918593A2 (pt) 2018-05-22
WO2010026469A1 (es) 2010-03-11
HN2011000661A (es) 2013-09-16
BRPI0918593B1 (pt) 2020-11-10
KR101653424B1 (ko) 2016-09-01
EP2329819A4 (en) 2011-09-14
KR20110050678A (ko) 2011-05-16
MX2008011321A (es) 2010-03-04
BRPI0918593B8 (pt) 2021-05-25
CA2735926A1 (en) 2010-03-11
EP2329819A1 (en) 2011-06-08
US20110166087A1 (en) 2011-07-07

Similar Documents

Publication Publication Date Title
EA200870154A1 (ru) Лекарственное средство для местного применения
ES2553742T3 (es) Forma de dosificación farmacéutica que comprende 6'-fluor-(N-metil- o N,N-dimetil)-4-fenil-4',9'-dihidro-3'H-espiro[ciclohexano-1,1'-pirano[3,4,b]indol]-4-amina
CL2012002126A1 (es) Composicion farmaceutica topica que comprende 1`-{[5-(trifluorometil)furan-2-il]metil}espiro[furo[2,3-f][1,3]benzodioxol-7,3`-indol]-2`(1`h)-ona; y uso para tratar, una enfermedad o condicion tal como dolor neuropatico, dolor quirurgico, dolor por trauma, dolor de cabeza cronico, entre otras.
MX2009003372A (es) Formas de dosificacion de pelicula no mucoadhesiva.
WO2007012022A3 (en) Unit dose form with ibuprofen-famotidine admixture
CL2011002858A1 (es) Uso de una composicion farmaceutica transmucosa oral que comprende dexmedetomidina y una sal farmaceuticamente aceptable y un excipiente farmaceuticamente aceptable para preparar un medicamento util para tratar o prevenir el dolor.
AR048705A1 (es) Composiciones farmaceuticas para el tratamiento de los trastornos sexuales ii
JP2010222367A5 (es)
MX2021000376A (es) Composiciones tópicas para el alivio del dolor.
CL2007000345A1 (es) Composicion farmaceutica que comprende una cantidad terapeuticamente efectiva de uno o mas agentes terapeuticos y una cantidad mejoradora de la absorcion intestinal de uno o mas agonistas de receptores de zonulina/zot; y uso de la composicion para tratar la diabetes.
MX2012005689A (es) Analogos de acido araquidonico y metodos para el tratamiento analgesico utilizando los mismos.
MX2009011900A (es) Curacion de herida diabetica.
WO2011074015A3 (en) Composition of pharmaceutical product to treat sexual dysfunction
CO6321156A2 (es) Composicion farmaceutica para el uso en el tratamiento de infecciones de transmision sexual
CL2010000524A1 (es) Uso de una composición tópica que comprende 3,75% de imiquimod y un portador farmacéuticamente aceptable para preparar un medicamento útil para tratar verrugas genitales o perianales.
AR061233A1 (es) Formulacion de liberacion prolongada de naltrexona
PE20120956A1 (es) Composicion farmaceutica que contiene buprenorfina y nalmefeno
CL2012003119A1 (es) Composicion farmaceutica para inyeccion que compende una solucion acuosa de ibuprofeno y trometamol, en que la concentracion de ibuprofeno esta entre 2 y 6 mg/ml, la concentracion de trometamol esta entre 1.8 y 5.8 mg/ml, y el ph esta entre 7,0 y 9,5; y su uso para el tratamiento del dolor, la inflamacion o la fiebre.
AR066666A1 (es) Composicion farmaceutica que comprende la combinacion de un agente antiinflamatorio no esteroideo y un agente anticonvulsivante
RU2011148355A (ru) Применение аллопуринола для ладонно-родошвенного синдрома
AR075866A1 (es) Una dosis de ave5026 para el tratamiento de tromboembolismo venoso en pacientes con deterioro renal severo. uso. composicion farmaceutica.
DOP2011000060A (es) Composicion farmaceutica para el uso en el tratamiento de infecciones de transmision sexual
CR20110106A (es) Composición farmacéutica para el uso en el tratamiento de infecciones de transmisión sexual
AR061046A1 (es) Mirtazapina para el tratamiento del dolor neuropatico
AR067320A1 (es) Composicion farmaceutica que comprende la combinacion de un agente antimicrobiano y un agente antioxidante para el tratamiento de infecciones urinarias

Legal Events

Date Code Title Description
FA Application withdrawn